Hamartoma screening

Hamartoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamartoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamartoma screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamartoma screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamartoma screening
CDC on Hamartoma screening
Hamartoma screening in the news
Blogs on Hamartoma screening
Directions to Hospitals Treating Hamartoma
Risk calculators and risk factors for Hamartoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Screening for sporadic hamartomas is not recommended. However, in case of familial inheritance hamartoses screening at early age is recommended.

Screening

Screening on familial hamartoma syndromes should include:

• Annual thyroid ultrasound and skin check with physical examination.
• Monthly breast self-examination; annual breast and endometrial screening (Mammogram,transvaginal ultrasound, biopsy, MRI may also be incorporated)
• Colonoscopy
• Renal imaging